首页> 外文OA文献 >Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis.
【2h】

Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis.

机译:比较考美唑,氨苄青霉素和氯霉素在治疗实验性乙型流感嗜血杆菌性脑膜炎中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To evaluate cotrimoxazole in the treatment of bacterial meningitis, we compared its action with that of ampicillin and chloramphenicol in experimental Haemophilus influenzae type b meningitis. Both trimethoprim and sulfamethoxazole penetrated well into the cerebrospinal fluid of infected rabbits, reaching 40 and 26%, respectively, of their simultaneous serum levels. Levels measured 30 and 60 min after intravenous injection exceeded the minimum inhibitory concentration of this combination for H. influenzae by 10- to 100-fold. The mean ratio of trimethoprim to sulfamethoxazole in cerebrospinal fluid was 1:22. Cotrimoxazole was as effective as ampicillin in therapy of beta-lactamase-negative H. influenzae meningitis and as effective as chloramphenicol for a beta-lactamase positive strain. These findings corroborate favorable preliminary clinical experience reported by others and indicate that cotrimoxazole deserves further study in the therapy of bacterial meningitis.
机译:为了评估cotrimoxazole在治疗细菌性脑膜炎中的作用,我们将其与氨苄西林和氯霉素在实验性乙型流感嗜血杆菌性脑膜炎中的作用进行了比较。甲氧苄啶和磺胺甲恶唑均能很好地渗透到感染兔子的脑脊液中,分别达到其同时血清水平的40%和26%。静脉注射后30和60分钟测得的水平超出了该组合对流感嗜血杆菌的最低抑制浓度10到100倍。脑脊液中甲氧苄啶与磺胺甲恶唑的平均比例为1:22。复方新诺明在治疗β-内酰胺酶阴性的流感嗜血杆菌脑膜炎方面与氨苄青霉素一样有效,而在β-内酰胺酶阳性菌株中与氯霉素一样有效。这些发现证实了其他人报道的有利的初步临床经验,并表明cotrimoxazole在细菌性脑膜炎的治疗中值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号